Breaking News
Sort by:
Date
Top Post
CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Top Pharmaceutical Companies and CROs Rely on Vivalink for Real-World Patient Data in Decentralized Clinical Trials
Due to limitations necessitated by COVID-19, clinical trials have undergone a transformation. In tandem with […]
Nearly Half of All Clinical Research Will Adopt Decentralized Clinical Trials Within Next Twelve Months, Survey Finds
VivaLNK, a leading provider of connected healthcare solutions, today announces the results of a survey of pharma, […]
- ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more
- Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas Read more
- Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform Read more
- FSD Pharma Receives Regulatory Clearance for Its Proposed Phase-1 Clinical Trial of Lucid-21-302 (Lucid-MS), First-in-Class Multiple Sclerosis Drug Candidate Read more
- $25 Million Gift to Penn Medicine and Children’s Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders Read more